PTPN11 mutations in noonan syndrome: Molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity

Marco Tartaglia, Kamini Kalidas, Adam Shaw, Xiaoling Song, Dan L. Musat, Ineke Van der Burgt, Han G. Brunner, Débora R. Bertola, Andrew Crosby, Andra Ion, Raju S. Kucherlapati, Steve Jeffery, Michael A. Patton, Bruce D. Gelb

Research output: Contribution to journalArticlepeer-review

594 Scopus citations

Abstract

Noonan syndrome (NS) is a developmental disorder characterized by facial dysmorphia, short stature, cardiac defects, and skeletal malformations. We recently demonstrated that mutations in PTPN11, the gene encoding the non-receptor-type protein tyrosine phosphatase SHP-2 (src homology region 2-domain phosphatase-2), cause NS, accounting for -50% of cases of this genetically heterogeneous disorder in a small cohort. All mutations were missense changes and clustered at the interacting portions of the amino-terminal src-homology 2 (N-SH2) and protein tyrosine phosphatase (PTP) domains. A gain of function was postulated as a mechanism for the disease. Here, we report the spectrum and distribution of PTPN11 mutations in a large, well-characterized cohort with NS. Mutations were found in 54 of 119 (45%) unrelated individuals with sporadic or familial NS. There was a significantly higher prevalence of mutations among familial cases than among sporadic ones. All defects were missense, and several were recurrent. The vast majority of mutations altered amino acid residues located in or around the interacting surfaces of the N-SH2 and PTP domains, but defects also affected residues in the C-SH2 domain, as well as in the peptide linking the N-SH2 and C-SH2 domains. Genotype-phenotype analysis revealed that pulmonic stenosis was more prevalent among the group of subjects with NS who had PTPN11 mutations than it was in the group without them (70.6% vs. 46.2%; P < .01), whereas hypertrophic cardiomyopathy was less prevalent among those with PTPN11 mutations (5.9% vs. 26.2%; P < .005). The prevalence of other congenital heart malformations, short stature, pectus deformity, cryptorchidism, and developmental delay did not differ between the two groups. A PTPN11 mutation was identified in a family inheriting Noonan-like/multiple giant-cell lesion syndrome, extending the phenotypic range of disease associated with this gene.

Original languageEnglish
Article number60707
Pages (from-to)1555-1563
Number of pages9
JournalAmerican Journal of Human Genetics
Volume70
Issue number6
DOIs
StatePublished - 2002

Fingerprint

Dive into the research topics of 'PTPN11 mutations in noonan syndrome: Molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity'. Together they form a unique fingerprint.

Cite this